Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F, Henquin JC
Regular follow-ups and monitoring ensure that any changes in heart rate are managed effectively, allowing patients to benefit from the metabolic advantages of semaglutide without compromising their cardiovascular safety
For simplicity, I am including results reported in studies 1-3
Sunamori M, Nakagawa T, Fujisawa S, and et al
You can change your regular dosing day if necessary, provided at least 3 days have passed since your last dose
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study